Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
Rachna MalaniMartin FleisherPriya KumthekarXuling LinAntonio OmuroMorris D GrovesNancy U LinMichelle MeliskoAndrew B LassmanSuriya JeyapalanAndrew SeidmanAnna SkakodubAdrienne BoireLisa M DeAngelisMarc RosenblumJeffrey RaizerElena PentsovaPublished in: Journal of neuro-oncology (2020)
Clinicaltrials.gov: NCT01325207; registered March 29th, 2011.